Cancer Incidence After Bariatric Surgery: Nordic Cohort Study Insights
Overview
This large Nordic cohort study found that bariatric surgery is associated with a reduced overall risk of cancer in individuals with obesity. The study provides robust evidence over up to 33 years of follow-up, highlighting significant reductions in obesity-related cancers, particularly in women.
Background
Obesity is linked to increased risk of multiple cancers through endocrine, inflammatory, and immune mechanisms. Bariatric surgery induces substantial and sustained weight loss, which may reduce cancer risk. Previous studies suggested a 30–50% reduction in overall cancer risk post-surgery but showed inconsistent results for specific cancer types. This study aimed to clarify these associations using comprehensive data from five Nordic countries with long-term follow-up.
Data Highlights
Outcome
Hazard Ratio (HR)
95% Confidence Interval (CI)
All cancers (excluding non-melanoma skin cancer)
0.84
0.79–0.89
Obesity-related cancers
0.77
0.71–0.83
Endometrial cancer (women)
0.52
0.39–0.69
Postmenopausal breast cancer (women)
0.78
0.68–0.90
Colon cancer
0.79
0.65–0.96
Lung cancer
1.10
0.85–1.42
Key Findings
Bariatric surgery was associated with a 16% reduction in overall cancer risk compared to obese individuals without surgery (HR 0.84, 95% CI 0.79–0.89).
Risk of obesity-related cancers decreased by 23% post-surgery (HR 0.77, 95% CI 0.71–0.83).
Women experienced a pronounced reduction in endometrial cancer risk by 48% (HR 0.52, 95% CI 0.39–0.69).
Postmenopausal breast cancer risk was reduced by 22% in women after surgery (HR 0.78, 95% CI 0.68–0.90).
Colon cancer incidence was significantly lower in the bariatric surgery group (HR 0.79, 95% CI 0.65–0.96).
No significant difference in lung cancer incidence was observed, suggesting smoking prevalence did not confound results.
Clinical Implications
Bariatric surgery should be considered not only for weight reduction but also for its potential to lower the risk of several obesity-related cancers, especially in women. Clinicians should incorporate cancer risk reduction into counseling for patients considering bariatric surgery. Long-term cancer surveillance remains important, but these findings support bariatric surgery as a strategy to mitigate cancer burden in obese populations.
Conclusion
This extensive Nordic cohort study confirms that bariatric surgery is associated with a significant reduction in overall and obesity-related cancer risk, particularly among women. These findings reinforce the role of bariatric surgery in comprehensive obesity management with cancer prevention benefits.
References
IARC 2016 -- Body Fatness and Cancer
NordOSCo Study Protocol 2023 -- Nordic Obesity Surgery Cohort
